Skip to content

Epidaurus · Treatment Guide · Alternative & Complementary Medicine

Going abroad for —

Regenerative Medicine Access

PRP, exosomes, and regenerative treatments availability

The country comparison

Which countries are best for regenerative medicine access

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

  1. 1 Germany DE 5.0/5 Good Germany demonstrates comprehensive excellence across all non-stem-cell regenerative modalities. PRP is widely available and professionally standardized through the DGOU Working Group (95 specialists). Exosome therapie... Full report
    The evidence behind this score 8 cited points
    • PRP therapy available across orthopedic, aesthetic, dental, sports medicine, and dermatologic domains at facilities in Berlin, Munich, Hamburg, Frankfurt, Düsseldorf, Kassel, Stuttgart, and other cities with DGOU Working Group (95 specialist members) providing professional standards
    • Exosome therapies offered at multiple providers (Dr. Juliane Bodo, Dr. Bianca Knoll, ANOVA IRM) with regulated pathways under EU ATMP framework (1394/2007) and Paul Ehrlich Institut oversight
    • Germany is birthplace of ACS/Orthokine (Orthogen AG, Düsseldorf, 1997/2003) with Dr. Wehling clinic treating international patients; over 60,000 patients worldwide received treatment
    • PRF and CGF standard in German dental/maxillofacial surgery with FORM (Frankfurt Oral Regenerative Medicine) group at Goethe University Frankfurt leading research and DGOU involvement in clinical standards
    • Regenerative aesthetics market mature with PRP facials, hair restoration, and combination protocols available at Noah Klinik, Dr. Kors, KOEBE KLINIK, Aesthé Clinic, and others with English-language services and international patient coordination
    • Germany is 5th most popular medical tourism destination globally with 12.7% of patients coming from abroad; multiple clinics explicitly market regenerative treatments to international patients with ANOVA IRM within 20 minutes of Frankfurt Airport
    • Licensed physicians required for PRP treatment; BIH Center for Regenerative Therapies at Charité Berlin and university hospitals in Rostock, Freiburg, Leipzig, Regensburg, Jena contribute to peer-reviewed research
    • 20+ identifiable facilities including dedicated regenerative medicine centers (ANOVA IRM, Dr. Wehling, BCRT), aesthetic clinics, and sports medicine providers across major cities; no regulatory crackdowns or safety incidents reported

    Read the full Germany report →

  2. 2 Japan JP 4.5/5 Good Japan demonstrates exceptional regenerative medicine access with comprehensive PRP availability across five clinical domains (orthopedic, dental, aesthetic, gynecologic, hair restoration), mature professional regulati... Full report
    The evidence behind this score 5 cited points
    • PRP dominates market at 66% of regenerative medicine provision plans as of January 2022, available across orthopedic, dental, aesthetic, gynecologic, and hair-restoration applications with documented use of FDA-cleared/CE-marked preparation systems (GPS® III, APS kit, MyCells); market valued at USD 32.73 million (2024) with projection to USD 89.93 million by 2032
    • Exosome therapies offered by 669 medical institutions with identified product sources (umbilical cord-derived, bone marrow, dental pulp), but operate outside current ASRM regulatory scope; JSRM issued world's first clinical EV guidance in April 2024 with supplemental clause committing to legal review by approximately 2027
    • Multiple dedicated regenerative medicine centers actively serving international patients with mature medical tourism infrastructure: BIANCA CLINIC (95 countries, free interpretation, WhatsApp 24-hour concierge), Rakan Clinic Tokyo (1-2 day visit protocols, University of Tokyo partnership), ISEIKAI International (MHLW-approved, English-language orthopedic services), NAG Orthopaedic Clinic (English operations, same-day appointments), Cell Grand Clinic Osaka (MEJ-accredited government body); treatment costs 30-50% below US pricing
    • All PRP providers required to register with MHLW-certified committees; 2024 amendment mandates regenerative medicine-qualified team members; no serious adverse events reported from platelet-concentrate therapies under NRMD surveillance system
    • Published clinical research includes 2,068-patient real-world dataset (2020-2024) and 2024 randomized controlled trial on leukocyte-poor PRP for knee osteoarthritis in Japanese population, demonstrating research-driven rather than purely commercial clinical practice

    Read the full Japan report →

  3. 3 Colombia CO 4.5/5 Good Colombia offers exceptional regenerative medicine access for medical tourists, with 533+ PRP providers across multiple cities spanning orthopedic, aesthetic, dental, sports medicine, and hair restoration applications.... Full report
    The evidence behind this score 6 cited points
    • 533 PRP providers documented on Doctoralia.co across Bogotá, Medellín, Cali, and Barranquilla; 6+ dedicated PRP-focused clinics identified through medical tourism aggregators
    • Multiple exosome therapy providers (LivCells GMP-certified, reju Stem Cell Clinic, Alevy, Dr. Aldana) though regulatory framework incomplete—INVIMA's Decree 2493/2004 covers tissue banking but lacks complete therapeutic exosome approval pathway
    • Prolotherapy with 25% dextrose published in Revista Colombiana de Ortopedia y Traumatología; PRF integrated across multiple dental implantology clinics
    • Professional societies: Asociación Colombiana de Medicina Regenerativa y Dolor and SCCOT (Sociedad Colombiana de Cirugía Ortopédica y Traumatología) featuring regenerative medicine at 2025 congress
    • Medical tourism infrastructure: 4 JCI-accredited hospitals, US/EU citizens visa-exempt for 90 days, 40-70% cost savings versus North America, English-language services, international patient coordinators
    • Primary regulatory gap: PRP technology validation standards not consistently documented; exosomes operate without defined pre-market regulatory pathway

    Read the full Colombia report →

  4. 4 United Kingdom GB 4.5/5 Good The UK demonstrates excellent regenerative medicine access across multiple modalities with strong regulatory clarity and high practitioner standards. PRP therapy is widely available across orthopedic, aesthetic, denta... Full report
    The evidence behind this score 8 cited points
    • PRP widely available across orthopedic, aesthetic, dental, and sports medicine at major hospital chains (Spire Healthcare, HCA UK, King Edward VII's Hospital, Royal Free Private Patients) and specialist clinics across multiple cities with documented use of Angel Arthrex and Magellan TruPRP systems
    • Injectable exosome therapy explicitly prohibited by MHRA (no UK marketing authorisation); topical non-injectable exosomes only permitted for cosmetics
    • Prolotherapy available from 9+ practitioners with British Institute of Musculoskeletal Medicine (BIMM) formal credentialing and GMC-linked credentialing pathway
    • Platelet-Rich Fibrin (PRF) available in specialist London dental practices (Maida Smiles, Sonria Dental Clinic, Optimal Dental Health)
    • Mature regenerative aesthetics market with dozens of CQC-registered clinics offering vampire facials from ~£250 and PRP hair restoration from £300–£545 per session
    • Dedicated regenerative medicine centers with international infrastructure: The Regenerative Clinic (5 UK locations, 2,700+ joints treated, partnerships in Dubai/Australia/Spain/Pakistan); Harley Street Specialist Hospital; major private hospitals with multilingual international patient coordination
    • 20+ identifiable facilities across London, Manchester, Birmingham, Liverpool, Exeter
    • Published NHS research on PRP efficacy for knee osteoarthritis and systematic reviews of injectable bio-revitalizers; practitioner standards enforced by MHRA (PRP manufacture restricted to GMC-registered medical doctors only); professional credentialing through BIMM

    Read the full United Kingdom report →

  5. 5 Israel IL 4.5/5 Good Israel demonstrates strong regenerative medicine access with PRP widely available across multiple specialties at dedicated clinics and major hospitals, supported by Israel-based Estar Medical's FDA- and CE-cleared PRP... Full report
    The evidence behind this score 8 cited points
    • Multiple PRP clinics (PRP Clinic, Leo Clinics, Biotec Clinic, Prolo-Cure, Regen-Orthopedics) and major hospital programs (Ichilov, Assuta, Hadassah, Herzliya) offering PRP across orthopedic, aesthetic, dental, hair restoration, and sports medicine specialties
    • Estar Medical (Holon, Israel) manufactures FDA- and CE-cleared PRP systems distributed in 60+ countries, providing world-class preparation technology
    • Israeli Ministry of Health requirement that PRP and regenerative procedures be performed exclusively by licensed physicians, with legal consequences for violations
    • Advanced regenerative modalities available: ACS/Orthokine at Regen-Orthopedics; PRF/CGF integrated into dental/periodontal practice; prolotherapy at Herzliya Medical Center and Prolo-Cure
    • Mature medical tourism infrastructure: 29 JCI-accredited hospitals, 92% English-speaking physicians, dedicated international patient departments at Sheba and Assuta, costs 60-70% below US
    • Sagol Center for Regenerative Medicine at Tel Aviv University (2022, partnership with Sheba) conducting translational research; Meir Medical Center with multiple PRP/PRGF randomized controlled trials
    • Exosome therapies available but operate in regulatory gray area with no Israeli Ministry of Health approval, no identified product sourcing, and no disclosed quality controls
    • No dedicated national professional society for regenerative medicine; practitioner credentialing flows through informal international training rather than coherent national system

    Read the full Israel report →

  6. 6 Turkey TR 4.5/5 Good Turkey demonstrates excellent regenerative medicine access across multiple modalities with extensive clinic networks (52+ PRP clinics, 21+ prolotherapy providers, 6-8 exosome facilities) and broad specialty applicatio... Full report
    The evidence behind this score 8 cited points
    • PRP availability: 52+ clinics across Turkey covering 6+ clinical specialties with documented use of FDA-cleared/CE-marked systems (Arthrex ACP, RegenLab) at JCI-accredited hospitals
    • Exosome therapy: 6-8 Istanbul providers including JCI-accredited hospitals; operating in regulatory grey area with inconsistent product provenance documentation at some providers
    • Prolotherapy/PRF: 21+ clinics across 5 cities; PRF widely adopted in Turkish dental practice with registered clinical trials on CGF/PRF combinations
    • Regenerative aesthetics: 500+ hair clinics in Istanbul; Turkey performs 40% of global hair transplants; PRP, exosome, and multi-modal regenerative protocols standard at hundreds of aesthetic clinics
    • Medical tourism infrastructure: 1.5 million international health tourists annually, 50+ JCI-accredited hospitals, major networks (Acibadem 24 hospitals, Memorial 12, MedicalPark 28), English-language services, dedicated patient coordinators, all-inclusive treatment packages with follow-up care
    • Clinical standards: PRP requires Ministry of Health licensed physician administration; senior practitioners at JCI hospitals document 25-29 years experience with 900+ documented procedures; Acibadem sports medicine centers hold FIFA accreditation
    • Published research: Turkish university hospitals contribute peer-reviewed PRP and CGF research to PubMed-indexed journals; registered clinical trials on ClinicalTrials.gov for PRP in orthopedics and CGF/PRF in dentistry
    • Quality concerns: 2020 peer-reviewed audit documented Turkish PRP online resources averaged 7.1/25 on quality scales; significant disparity between JCI-accredited hospital standards and 500+ commercial hair clinics

    Read the full Turkey report →

  7. 7 Thailand TH 4.5/5 Good Thailand demonstrates excellent regenerative medicine access with PRP widely available across multiple specialties at 12+ identifiable facilities and 15-20+ total providers, a rapidly expanding exosome market (242 ser... Full report
    The evidence behind this score 6 cited points
    • 242 exosome services listed on GoWabi platform across Thailand as of 2025, with products sourced from established Korean (ExoCoBio ASCE+), American (BENEV, Kimera Labs), and other manufacturers
    • PRP therapy available at major JCI-accredited hospitals (Bumrungrad, Samitivej with 38 specialists treating 5,000+ athletes, Bangkok Hospital, BNH, Vejthani) and dozens of specialty clinics across multiple cities, with FDA-cleared/CE-marked preparation systems documented
    • Thailand's FDA has not issued exosome-specific regulations; these treatments operate without dedicated safety or efficacy requirements beyond general medical practice licensure—a significant regulatory gap acknowledged as the most critical concern for medical tourists
    • 62 JCI-accredited medical facilities (4th highest globally) and 3.5 million+ international patients annually, with dedicated medical treatment visa introduced January 2023 explicitly covering regenerative medicine for up to 90 days
    • Professional certifications available through A4M Thailand (ABAARM) and ABAM Bangkok training center, supporting practitioner training and credentials in regenerative medicine across the region
    • Multiple modalities available: PRP across orthopedic/aesthetic/dental/hair restoration, exosome therapy, prolotherapy, platelet-rich fibrin (PRF), and autologous conditioned serum (ACS/Orthokine) with documented clinical protocols

    Read the full Thailand report →

  8. 8 United Arab Emirates AE 4.5/5 Good The UAE demonstrates excellent regenerative medicine access with 20+ identified facilities offering PRP, exosome, prolotherapy, and advanced orthobiologics across multiple specialties and cities. Top-tier internationa... Full report
    The evidence behind this score 6 cited points
    • 20+ identifiable regenerative medicine facilities across Dubai, Abu Dhabi, and Sharjah, including major hospital networks (Cleveland Clinic Abu Dhabi, Mediclinic, Mubadala Health, Aster Hospitals) offering PRP, exosome, prolotherapy, PRF, CGF, GOLDIC, and HPL therapies
    • DHA Standards for Stem Cells and Regenerative Medicine (ST-68, February 2025) establishing mandatory GMP/GLP/GCP/GTP compliance and formal regulatory pathway for exosome and regenerative products
    • Ultrasound-guided PRP procedures documented at top institutions; prolotherapy administered by USA-trained Physical Medicine and Rehabilitation consultant at Mubadala Health Dubai with ultrasound guidance
    • World-class medical tourism infrastructure: DHA's "Dubai in One Day" same-day scheduling, medical visa facilitation (3-6 months), multilingual concierge services, and medical tourism facilitator platforms (My1Health, PlacidWay, MyMediTravel)
    • Advanced modalities beyond standard PRP: GOLDIC (gold-induced autologous conditioned serum) at DRHC Dubai, CGF at Euromed Clinic and Royal Clinic, HPL at ADSCC; published peer-reviewed research on CGF efficacy from University Dental Hospital Sharjah
    • Acknowledged red flags: variable exosome product provenance disclosure across providers, no FDA/EMA exosome product approval globally, marketing claims in aesthetics sector without independent outcome data, and variable practitioner credentials documentation at smaller clinics

    Read the full United Arab Emirates report →

  9. 9 India IN 4.5/5 Good India demonstrates excellent regenerative medicine access across most dimensions: PRP is widely available across multiple specialties (orthopedic, aesthetic, dental, sports medicine, hair restoration) at hundreds of f... Full report
    The evidence behind this score 6 cited points
    • PRP available across orthopedic, aesthetic, dental, sports medicine, hair restoration at hundreds of facilities in 12-16+ major cities including DHI (16 cities), Oliva (10+ cities), and major hospital chains (Apollo, Fortis, Kokilaben, BLK-Max, Nanavati Max)
    • Exosome therapies available from multiple providers (Dr. Batul Patel, Viva Aesthetic Clinic, Derma Curve, R3 Stem Cell India, The Esthetic Clinics, Adorn Clinic) with DCGI approval of Meta Cell Technology (June 2025) as India's first autologous exosome injectable and formal classification of minimally manipulated exosome procedures as low-risk aesthetic services
    • Prolotherapy available at ~24 clinics across major metros including India's first dedicated prolotherapy clinic led by FIRO-certified Dr. Vikram Rajguru; BLK-Max and Nanavati Max hospitals also offer prolotherapy
    • Advanced PRP guidelines published 2025 by Advanced Regenerative Medicine India Group; Arthrex CE-marked centrifuge systems confirmed in use; Indian Association of Dermatologists published double-spin protocol with specific parameters
    • Medical tourism infrastructure: 40+ JCI-accredited hospitals, 507,244 foreign medical tourists in 2025, Apollo treats patients from 150+ countries with dedicated international services, costs 60-80% below Western benchmarks
    • Professional society infrastructure: Indian Biologics Orthopaedic Society, Indian Cartilage Society, Indian Association of Sports Medicine co-organize ReGen India Conference; MIRM (Manipal) Asia's first dedicated regenerative biology program; India accounts for 4% of WHO EV-based clinical trials

    Read the full India report →

  10. 10 Jordan JO 4.0/5 Good Jordan demonstrates good regenerative medicine access with PRP widely available across multiple clinical specialties (orthopedic, aesthetic, hair restoration) documented in over 160 facial rejuvenation and 80+ hair lo... Full report
    The evidence behind this score 5 cited points
    • Over 160 PRP facial rejuvenation doctors and 80+ PRP hair loss practitioners documented on Tebcan, indicating widespread availability across multiple clinical specialties and geographic distribution beyond Amman
    • PRF explicitly offered at RAF Clinic and Dr. Denian Clinic Regenerative Med Rehab, demonstrating multiple trained practitioners with advanced blood-concentrate technologies
    • Exosome therapy available at RAF Clinic, Dr. Karam Mahsiry Clinic, and Dr. Alghoul's clinic, though JFDA has no exosome-specific regulatory guidance creating a gray-area regulatory environment
    • Cell Therapy Center at University of Jordan has published research on platelet-derived biologics and conducted registered clinical trials (NCT02972528) on platelet lysate for diabetic foot ulcers
    • Prolotherapy absent from documented clinical offerings despite search across Tebcan, Vezeeta, and OrthoSportJordan directories listing 63-100 Amman orthopedists

    Read the full Jordan report →

  11. 11 Brazil BR 4.0/5 Good Brazil demonstrates good regenerative medicine access with 20+ identifiable facilities offering multiple modalities across major cities, strong professional education infrastructure (Orthoregen MEC-recognized speciali... Full report
    The evidence behind this score 8 cited points
    • 20+ identifiable PRP facilities across São Paulo, Rio de Janeiro, Brasília, Curitiba, and Belo Horizonte offering orthopedic, aesthetic, sports medicine, and hair restoration applications
    • Prolotherapy well-established with multiple credentialed specialists (Dra. Camila Lobo, Dr. Marcio Rubin, Dr. Lucas Fonseca, pain management institutes)
    • PRF fully integrated into dental care under CFO Resolution 158/2015 with institutional training at São Leopoldo Mandic and Instituto Praxis
    • R3 Stem Cell international patient network across 11 Brazilian cities with English-language coordination and established medical tourism infrastructure
    • Brazil holds 42% of Latin America's bioregenerative aesthetic injectable market; PDRN-approved compliant alternative available for regenerative aesthetics
    • Professional standards infrastructure: Orthoregen MEC-recognized postgraduate specialization with ABRM/AARM certifications, SBRET scientific society, SBCOC 2024 clinical manual
    • CFM classifies PRP as experimental therapy with regulatory restrictions; ANVISA September 2024 guidance identifies quality control variability and infection risks from uncontrolled production
    • Injectable exosome therapies prohibited by ANVISA and SBD for injectable use; only topical exosome cosmetics registered; some non-compliant providers operate outside legal framework

    Read the full Brazil report →

  12. 12 Spain ES 4.0/5 Good Spain offers good-to-excellent regenerative medicine access with widely available PRP therapy across multiple specialties (orthopedics, aesthetics, dentistry, pain medicine, ophthalmology) at 15+ documented facilities... Full report
    The evidence behind this score 7 cited points
    • PRP available across 7+ clinical specialties (orthopedics, aesthetics, dental, sports medicine, pain, trichology, ophthalmology) with AEMPS-regulated CE-marked equipment and mandatory serological testing per 2013 framework updated July 2024
    • 15+ identifiable facilities including two JCI-accredited hospitals (Ruber Internacional, Teknon), dedicated centers (BTI, Hospital Capilar, Regenerat), and AEMR-accredited clinics across Barcelona, Madrid, Valencia, Alicante, and other cities
    • Prolotherapy available from multiple credentialed practitioners (Regenerat Clinic 5 locations, Quirónsalud Alicante, Clínica ITRAMED); PRF routine in Spanish dental clinics per SEPA; Orthokine available through Vithas network
    • Exosome therapies available from multiple providers (Ilahy 6 locations, De Felipe 3+ locations, others) but SEME explicitly warns procedures are outside approved treatment protocols, no EMA authorization exists, and product sources include 30+ international companies with no standardization
    • Professional societies provide standards: AEMR clinic accreditation, SEMDOR Specialist Title in Regenerative Medicine, SEMDOR 2025 PRP consensus guide, Spain leads EU with 52 ATMP trials authorized in 2024
    • Established medical tourism infrastructure with JCI accreditation, multilingual staff, international patient coordinators, treatment packages, cost savings 30-70% vs US/UK, acceptance of international insurers (Cigna, DKV)
    • Published clinical research: randomized controlled trial on intra-articular PRP vs hyaluronic acid from Spanish NHS hospital; dextrose prolotherapy study in Reumatología Clínica; research contributions from IMDEA, University of Valladolid, IBEC

    Read the full Spain report →

  13. 13 Hungary HU 4.0/5 Good Hungary demonstrates good regenerative medicine access with strong infrastructure concentrated in Budapest. PRP therapy is readily available across multiple specialties (orthopedic, aesthetic, dental, pain management)... Full report
    The evidence behind this score 4 cited points
    • PRP therapy available at 13+ identifiable Budapest clinics across orthopedic, aesthetic, hair restoration, and pain management specialties, using US-imported EmCyte and APEX preparation systems
    • Prolotherapy available from Dr. Ágnes Stogicza (MD, PhD, FIPP, CIPS), internationally credentialed pain medicine specialist who co-founded Pain School International training 200+ international physicians
    • Regenerative aesthetic treatments (vampire facials, PRP hair restoration, exosome microneedling) offered by multiple clinics (Zenon Clinic, MEDISMILE, Dr. Pellion, Aesthetica, Aestella Klinika) with established English-language medical tourism infrastructure and patient coordination
    • All regenerative medicine providers concentrated in Budapest only; exosome therapies limited to 1-2 emerging providers (Aestella Klinika documented); no dedicated multi-modal regenerative medicine center identified

    Read the full Hungary report →

  14. 14 South Korea KR 4.0/5 Good South Korea meets or exceeds Score 4 criteria across all dimensions: PRP is widely available across 5+ specialties at dozens of clinics with advanced centrifuges; prolotherapy and PRF are formally recognized and offer... Full report
    The evidence behind this score 6 cited points
    • PRP available across orthopedic, aesthetic, dental, hair restoration, and sports medicine at 15-20+ identifiable Seoul clinics using advanced closed-system centrifuges and ultrasound guidance
    • Prolotherapy formally recognized as new health technology by Korea's nHTA Committee (2023); offered at specialist clinics by university-trained orthopedists
    • Platelet-rich fibrin (PRF) established in Korean dentistry with at least 8 identifiable PRF clinics; Korean Association of Shockwave and Regenerative Medicine (KASRM) offers KCC certification
    • Regenerative aesthetics market mature: vampire facials, exosome facials, PRP hair restoration, and combination protocols standard in Gangnam; 30% of practitioners identify PRP/exosome as top patient interest
    • Medical tourism infrastructure exceptional: 1.17 million foreign patients in 2024 (93.2% YoY growth), government-licensed coordinators, English-language clinics, condensed treatment schedules, remote aftercare
    • Exosome regulatory gap: no injectable exosome product approved by MFDS; MFDS banned 'exosome' in cosmetic advertising (January 2025); off-label use documented with adverse reactions (granulomas, scarring, necrosis in 2025 case series)

    Read the full South Korea report →

  15. 15 Mexico MX 4.0/5 Good Mexico demonstrates good regenerative medicine access with PRP therapy widely available across multiple specialties (orthopedic, aesthetic, dental, sports medicine, hair restoration) at numerous facilities in 7+ citie... Full report
    The evidence behind this score 7 cited points
    • PRP therapy available across orthopedic, aesthetic, dental, sports medicine, and hair restoration in major cities (Tijuana, Cancun, Guadalajara, Mexico City, Mexicali, Puerto Vallarta, Los Algodones) at cost savings of 50-60% vs US
    • Prolotherapy tradition established through decades of Hackett-Hemwall-Patterson Foundation annual brigades in Guadalajara and AAOM workshops; Dr. Wajid Burad treated 5,000+ prolotherapy cases in 5 years as clinical director
    • Multiple exosome providers including R3 Stem Cell Mexico (Tijuana/Cancun), Holistic Bio Spa, CellRegen Clinic, and PRMEDICA Inc., though no exosome product has FDA approval or approval from any major regulatory agency globally
    • Medical tourism infrastructure well-developed along US-Mexico border with 660,000 medical border crossings in December 2023; clinics offer English-language services, patient coordination, chaperoned transportation, and same-day treatment options
    • 16-20+ identifiable regenerative medicine facilities including Holistic Bio Spa, CellRegen Clinic, R3 Stem Cell, SPORTMED (only FIFA/FIMS dual-accredited facility in Latin America), plus 76 confirmed locations in Tijuana alone
    • Critical licensing verification failure: 2021 web surveillance study found only 1 of 13 Tijuana clinics claiming COFEPRIS licensing could be matched with available licensing records; 99.1% of surveyed clinics lacked academic institutional affiliations
    • COFEPRIS licensing framework requires on-site inspections, equipment verification, and medical education credentials; Mexico adopted US hospital accreditation standards via formal JCAHO agreement with 9 JCI-accredited facilities

    Read the full Mexico report →

  16. 16 Malaysia MY 4.0/5 Good Malaysia demonstrates good regenerative medicine access for medical tourists with approximately 80 PRP clinics across multiple specialties (orthopedic, aesthetic, dental, gynecologic), 12+ exosome therapy providers us... Full report
    The evidence behind this score 7 cited points
    • Approximately 80 PRP clinics nationwide across orthopedic, aesthetic, dental, and gynecologic applications on Erufu Care provider directory
    • 12+ exosome therapy clinics in Kuala Lumpur using GMP-certified ASCE+ formulations from South Korean manufacturers with certificates of analysis
    • Malaysia Healthcare Travel Council (MHTC) established 2009 with government backing; 2026 designated Malaysia Year of Healthcare Travel
    • LCP tiered credentialing system mandatory for aesthetic practitioners with MMC registration requirement plus 2+ years supervised experience and case logbook documentation
    • MSAM (Ministry of Health-endorsed) and SAAARMM professional societies provide standards; 2022 Frontiers review published by Universiti Malaya researchers documents active research ecosystem
    • Prolotherapy limited to 3-4 identifiable clinics; NPRA has not issued specific regulatory guidance for exosome products despite 2024 public consultation on Cell and Gene Therapy Products guidelines
    • PMC peer-reviewed study (2024) identified enforcement gaps in Malaysia's aesthetic medicine sector with documented complications from 2014, 2020, and 2022

    Read the full Malaysia report →

  17. 17 Poland PL 4.0/5 Good Poland demonstrates strong regenerative medicine access meeting all Score 4 criteria and exceeding most Score 5 criteria. PRP therapy is widely available across 5+ specialties with CE-marked systems at 15+ documented ... Full report
    The evidence behind this score 6 cited points
    • 15+ clinics offering regenerative treatments across Warsaw, Krakow, Wroclaw, Lodz, Gdansk, Zielona Góra, and Płock
    • PRP available across orthopedic, aesthetic, hair restoration, dental, and sports medicine with CE-marked systems (Angel System®, Tropocells PRP™, RegenLab, Arthrex ACP)
    • Exosome therapies (ASCE+) available at Wellclinic, Nowa Estetyka, Arcadia Clinic, NOVACELL networks, but no identified EU or Polish regulatory approval
    • PRF/I-PRF documented at dental clinics; ACS/Orthokine at certified Bio Ortopeda; PRGF and A2M available through multimodal programs
    • Polskie Towarzystwo Medycyny Regeneracyjnej professional society with leadership at Pomeranian Medical University; active research at Medical Universities of Warsaw, Wroclaw, and Gdańsk
    • Medical tourism infrastructure: 700,000+ non-resident medical tourists in 2024, English-speaking staff, multilingual support (9 languages at some clinics), international patient coordinators, costs 60-70% below Western Europe/US

    Read the full Poland report →

  18. 18 Singapore SG 3.5/5 Moderate Singapore offers strong orthopedic and sports medicine PRP delivered by specialist physicians at 12+ facilities, with exosome therapy from 7+ aesthetic clinics and prolotherapy from credentialed practitioners. However... Full report
    The evidence behind this score 5 cited points
    • At least 10–12 specialist clinics offer orthopedic/sports medicine PRP with ultrasound guidance and quality preparation protocols, but PRP is explicitly prohibited for all aesthetic and dermatological applications by Singapore's Ministry of Health
    • Exosome therapies available from 7+ aesthetic clinics (primarily topical ASCE brand via microneedling), but no injectable exosome product holds HSA approval; regulatory framework is ambiguous for topical products
    • Prolotherapy and PRF available from multiple credentialed practitioners including internationally certified pain specialists and dental centers, demonstrating quality professional standards
    • Excellent general medical tourism infrastructure (500,000+ international patients; major hospitals with dedicated international patient services), but regenerative medicine as a category is not strongly marketed to inbound tourists
    • World-class clinical research foundation (A*STAR exosome research, REMEDIS institute, Singapore-approved Phase 1 exosome trial) provides scientific credibility despite commercial limitations

    Read the full Singapore report →

  19. 19 United States US 3.5/5 Moderate The US has world-leading PRP therapy availability at 80+ Regenexx sites plus major academic centers spanning all specialties with FDA-cleared devices, and the most mature prolotherapy credentialing infrastructure glob... Full report
    The evidence behind this score 4 cited points
    • PRP available at 80+ Regenexx locations across 37 states plus Johns Hopkins, Penn Medicine, NYU Langone, Mayo, Emory, Mass General Brigham; FDA-cleared devices (Arthrex ACP Max, EmCyte PurePRP) standard; available across orthopedic, sports medicine, hair restoration, aesthetics, dental, wound care, and gynecologic applications
    • Prolotherapy credentialed by American Osteopathic Association of Prolotherapy Regenerative Medicine (AOAPRM) since 1938 and American Board of Prolotherapy since 1989; integrated into academic medical centers including Mass General Brigham and Regenexx network; Journal of Prolotherapy is peer-reviewed publication
    • Zero FDA-approved exosome products as of June 2026; FDA issued 12+ warning letters (Evolutionary Biologics, Chara Biologics, Supreme Rejuvenation, New Life Medical Services, Dynamic Stem Cell Therapy); criminal prosecutions including 36-month federal sentence September 2024; exosome products offered at hundreds of aesthetic clinics with uncertain regulatory compliance and product provenance
    • US functions as outbound medical tourism source, not inbound destination; lacks dedicated regenerative medicine medical tourism facilitators, bundled packages, or international patient infrastructure; treatment costs $500–$2,500/session compared to $200–$400 at comparable-quality clinics in Mexico City or Seoul; English-language services universal but no differentiated medical tourism infrastructure

    Read the full United States report →

Reading the field

What separates a good programme from a dangerous one

Every country above is graded against this published scale — the same 1–5 rubric for regenerative medicine access, top to bottom. How we score →

  1. 5/5 Excellent Regenerative Medicine Access

    - PRP therapy is widely available across multiple clinical specialties (orthopedic, aesthetic, dental, sports medicine) at numerous facilities in multiple cities, with documented use of advanced PRP preparation systems (FDA-cleared or CE-marked devices) - Exosome therapies are available from multiple providers with clearly identified product sources and at least a defined regulatory pathway (approved or formally regulated) - Prolotherapy and/or PRF/CGF therapies are available from credentialed practitioners with professional society recognition - A mature regenerative aesthetics market exists with multiple clinics marketing regenerative treatments to international patients - Dedicated regenerative medicine centers or institutes exist with established medical tourism infrastructure (multilingual staff, international patient coordination, treatment packages) - Professional societies or credentialing bodies provide standards or certifications for regenerative medicine practitioners - Published clinical research on regenerative medicine originates from the country's institutions - At least 15-20+ facilities offering regenerative treatments identifiable through public sources

  2. 4/5 Good Regenerative Medicine Access

    - PRP therapy is readily available across at least 2-3 clinical specialties at multiple facilities, with evidence of quality preparation systems - Exosome therapies are available from at least a few providers, though regulatory status may be ambiguous - Prolotherapy or PRF is available from multiple trained practitioners - Regenerative aesthetic treatments are available and marketed to medical tourists - Some clinics have English-language services and experience with international patients - Practitioner qualifications are generally strong (specialists with additional regenerative medicine training) - At least 8-15 facilities offering regenerative treatments identifiable through public sources

  3. 3/5 Moderate Regenerative Medicine Access

    - PRP therapy is available but may be limited to 1-2 clinical applications or concentrated in major cities only - Exosome therapies may be emerging or available from a small number of providers - Prolotherapy or other regenerative injection therapies have limited but identifiable availability - Some regenerative aesthetic treatments are available - Medical tourism infrastructure for regenerative treatments is developing but not mature - At least 4-8 facilities offering regenerative treatments identifiable through public sources

  4. 2/5 Limited Regenerative Medicine Access

    - PRP therapy is available at only a small number of facilities, possibly limited to a single application area - Exosome therapies are absent or available from only one or two unregulated providers - Prolotherapy and other regenerative injection therapies are rare or absent - Regenerative aesthetic treatments are minimal - Little or no medical tourism infrastructure exists for regenerative treatments - Only 1-3 facilities offering regenerative treatments identifiable through public sources

  5. 1/5 Minimal or No Regenerative Medicine Access

    - PRP therapy is rare or effectively unavailable for medical tourists - No exosome therapies available - No prolotherapy or other regenerative injection therapies identifiable - No regenerative aesthetic market - No medical tourism infrastructure for regenerative treatments - No identifiable facilities offering regenerative treatments through public sources, or treatments are explicitly prohibited ---

The reports

The full country reports under this lens

Each destination we have assessed has a full, cited report — the detailed analysis behind its score. The verdict is free; the report is the depth.

Clinics & providers

The clinics our research names

Named hospitals, clinics and centres cited across these findings — each carrying the specialties our reports record. Follow one to the reports behind it.

References

The sources behind these assessments

The distinct sources cited across these published reports — every finding carries its own citations; this is the union, each linking back to the reports that lean on it.

  1. Untitled source acibademinternational.com/health-tourism Cited in Regenerative Medicine Access in Turkey
  2. Untitled source acibademinternational.com/treatment/orthopedics-sports-medicine Cited in Regenerative Medicine Access in Turkey
  3. Untitled source aseanhealthcare.org/asean_mra/detail/1/10 Cited in Regenerative Medicine Access in Thailand
  4. Untitled source bangkokdentalcenter.com Cited in Regenerative Medicine Access in Thailand
  5. Untitled source carelyclinic.com/medical-tourism-in-turkey-2025 Cited in Regenerative Medicine Access in Turkey
  6. Untitled source cms-lawnow.com/en/ealerts/2023/07/hungary-s-pharma-authority-to-merge-with-the-national-public-health-centre Cited in Regenerative Medicine Access in Hungary
  7. Untitled source dmcquote.com/guides/medical-tourism-thailand Cited in Regenerative Medicine Access in Thailand
  8. Untitled source dradas.com Cited in Regenerative Medicine Access in Jordan
  9. Untitled source elithair.com/uk/blog/exosome-therapy-for-hair-loss Cited in Regenerative Medicine Access in United Kingdom
  10. Untitled source en.wikipedia.org/wiki/Turkish_Medical_Association Cited in Regenerative Medicine Access in Turkey
  11. Untitled source fineupclinic.com/blog/health-tourism-statistics-in-turkey-2024 Cited in Regenerative Medicine Access in Turkey
  12. Untitled source globalmedik.com/en/medical-tourism-in-turkey-top-10-clinics-for-international-patients Cited in Regenerative Medicine Access in Turkey
  13. Untitled source iconicthai.com/thailand-medical-tourism-guide-a-comprehensive-overview-of-healthcare-services-2025 Cited in Regenerative Medicine Access in Thailand
  14. Untitled source jivaka.kr/blogs/blog/korean-medical-tourism-2026-complete-guide-to-changes-benefits-what-you-need-to-know Cited in Regenerative Medicine Access in South Korea
  15. Untitled source mkkmedica.pl/zabieg/egzosomy Cited in Regenerative Medicine Access in Poland
  16. Untitled source my1health.com/guides/medical-tourism-in-turkey-a-step-by-step-guide-for-international-patients Cited in Regenerative Medicine Access in Turkey
  17. Untitled source omcmedical.com/turkey-titck-turkiye-ilacvetibbicihazkurumu-approval-processes-for-biological-products Cited in Regenerative Medicine Access in Turkey
  18. Untitled source parentsguidecordblood.org/en/news/regenerative-medicine-clinics-mexico Cited in Regenerative Medicine Access in Mexico
  19. Untitled source piotrturkowski.pl/en Cited in Regenerative Medicine Access in Poland
  20. Untitled source pmc.ncbi.nlm.nih.gov/articles/PMC3564822 Cited in Regenerative Medicine Access in Thailand
  21. Untitled source pmc.ncbi.nlm.nih.gov/articles/PMC7977255 Cited in Regenerative Medicine Access in Mexico
  22. Untitled source pmc.ncbi.nlm.nih.gov/articles/PMC9597240 Cited in Regenerative Medicine Access in South Korea
  23. Untitled source r3antiaging.com/india Cited in Regenerative Medicine Access in India
  24. Untitled source rafclinic.com/microneedling Cited in Regenerative Medicine Access in Jordan

Explore the source archive →

In plain language

Start exploring the knowledge base

The field's shorthand our reports use, sized by how often it comes up. Follow any term to its full entry and the reports that use it.

For readers weighing this decision

Ways to read the evidence

The verdict is always free. A membership opens the full analysis and every cited source — this specialty, the whole library, or everything for good.

  • One specialty · annual

    Alternative & Complementary Medicine

    $49.00 / year

    $49.00/year

    Every report in this specialty — full analysis and every cited source — as each is published.

    Take this specialty

  • Full library · annual

    The whole library

    $199.00 / year

    $199.00/year

    The complete evidence behind every finding in every specialty, while your decision is live.

    Take the full library
  • Most readers

    Lifetime · one payment

    Everything, for good

    $499.00 once

    $499.00 (one-time)

    Every finding we publish today and hereafter — no renewal, no expiry. The tier we point most readers to.

    Take lifetime access

Prefer to pay per report? A single report is $29.00, yours to keep — browse the reports. The verdict is always free.

Where to go from here · Regenerative Medicine Access

no scope is a dead end — step up to the specialty, drill into a factor, or pivot across to a country or a comparison